Status:
RECRUITING
Reliability of a Food Frequency Questionnaire in the Assessment of Dietary Intake Including FODMAPs in Different Populations, and Relationship With IBS Symptoms and the Degree of Self-assessed Physical Activity
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
During an online assessment participants will fill in questionnaires evaluating demographic data, psychological variables, the degree of self-assessed physical activity and symptoms of irritable bowel...
Eligibility Criteria
Inclusion
- 18 - 65 years;
- Provide written informed consent;
- Living in Belgium
Exclusion
- Diet \< 8 weeks prior to participation;
- Known or suspected eating disorder;
- Major psychiatric disorder;
- Known gastro-intestinal disease (IBS is allowed);
- Any malignancy in the past 3 years (basocellular carcinoma is allowed);
- Chemotherapy in the past 6 months;
- Infectious gastro-enteritis in the past 6 months (infectious gastro-enteritis defined as the concurrent presence of one of the following signs during 2 or more consecutive days: fever, vomiting, sudden onset of diarrhea, hospitalization because of these symptoms);
- Previous abdominal surgery (appendectomy and cholecystectomy are allowed);
- Alcohol abuse defined as \> 14 U per week;
- Use of illicit drugs;
- Intake of drugs with known major gastro-intestinal side effects.
- Initiation of neuromodulators less than 3 months before participation. Neuromodulators are allowed when taken at a stable dose for at least 3 months;
- Pregnancy.
Key Trial Info
Start Date :
October 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05293769
Start Date
October 15 2022
End Date
December 31 2030
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Jette, Brussels Capital, Belgium, 1090